CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma

Name: CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic melanoma, stage iv cutaneous melanoma ajcc v6 and v7

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 160361
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.